These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 6836774

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [High-density lipoproteins in children with coronary diseases].
    Oberhänsli I, Pometta D, Micheli H, Raymond L.
    Helv Paediatr Acta; 1981; 36(2):135-47. PubMed ID: 7251385
    [Abstract] [Full Text] [Related]

  • 3. [The LDL-HDL ratio in patients with coronary arteriosclerosis (author's transl)].
    Zimmer F, Riebeling V, Benke B, Schuster J, Roskamm H.
    Z Kardiol; 1980 Mar; 69(3):149-53. PubMed ID: 7456590
    [Abstract] [Full Text] [Related]

  • 4. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial.
    Otvos JD, Collins D, Freedman DS, Shalaurova I, Schaefer EJ, McNamara JR, Bloomfield HE, Robins SJ.
    Circulation; 2006 Mar 28; 113(12):1556-63. PubMed ID: 16534013
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [LDL-cholesterol and HDL-cholesterol--risk factor and safety factor? Conclusions for therapy].
    Wolfram G, Schlierf G.
    Internist (Berl); 1979 Dec 28; 20(12):613-8. PubMed ID: 232882
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Lipid measurements for coronary risk assessment: a review.
    Berg LH.
    Am J Med Technol; 1981 Jul 28; 47(7):539-43. PubMed ID: 7025628
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The peculiarities of lipid and protein components of the high- and low-density lipoproteins in patients suffering from coronary atherosclerosis with different number of affected coronary arteries.
    Gasilin VS, Kurdanov KhA, Perova NV, Torkhovskaya TI, Polessky VA, Matveeva LS.
    Cor Vasa; 1981 Jul 28; 23(4):248-56. PubMed ID: 7297073
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Serum cholesterol binding reserve (SCBR) in coronary artery disease.
    Chandra R, Sikka KK, Kumar S, Srivastava DK.
    Indian Heart J; 1980 Jul 28; 32(6):355-60. PubMed ID: 7228084
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [The lipoproteic state in patients with coronary heart disease (author's transl)].
    Catalano M, Carzaniga G, Garimoldi M, Sala R, Castelfranco M, Libretti A.
    G Ital Cardiol; 1981 Jul 28; 11(12):1944-7. PubMed ID: 7346295
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Management of hyperlipidemia in coronary artery disease.
    Kossmann CE.
    J Tenn Med Assoc; 1982 Aug 28; 75(8):543-7. PubMed ID: 7132342
    [No Abstract] [Full Text] [Related]

  • 17. [Clinical significance of HDL-cholesterol].
    Reuter W, Herrmann W.
    Z Gesamte Inn Med; 1981 Jul 15; 36(14):473-9. PubMed ID: 6944971
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Lipoproteins, cardiovascular disease, and death. The Framingham study.
    Gordon T, Kannel WB, Castelli WP, Dawber TR.
    Arch Intern Med; 1981 Aug 15; 141(9):1128-31. PubMed ID: 7259370
    [Abstract] [Full Text] [Related]

  • 20. [Levels of lipoprotein fractions in ischaemic cerebral disease (author's transl)].
    Deisenhammer E, Sommer R, Teufl W.
    Wien Klin Wochenschr; 1982 Jan 22; 94(2):42-3. PubMed ID: 7080496
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.